![Short‑ and long‑term treatment with angiotensin‑converting enzyme inhibitors or calcium channel blockers for the prevention of diabetic nephropathy progression: A meta‑analysis Short‑ and long‑term treatment with angiotensin‑converting enzyme inhibitors or calcium channel blockers for the prevention of diabetic nephropathy progression: A meta‑analysis](https://www.spandidos-publications.com/article_images/etm/21/1/etm-21-01-09446-g05.jpg)
Short‑ and long‑term treatment with angiotensin‑converting enzyme inhibitors or calcium channel blockers for the prevention of diabetic nephropathy progression: A meta‑analysis
![Summary of pharmacological treatment. ACEI = angiotensin-converting... | Download Scientific Diagram Summary of pharmacological treatment. ACEI = angiotensin-converting... | Download Scientific Diagram](https://www.researchgate.net/publication/320698219/figure/fig2/AS:613985883799570@1523397050385/Summary-of-pharmacological-treatment-ACEI-angiotensin-converting-enzyme-inhibitors.png)
Summary of pharmacological treatment. ACEI = angiotensin-converting... | Download Scientific Diagram
![Angiotensin System Blockade Combined With Calcium Channel Blockers Is Superior to Other Combinations in Cardiovascular Protection With Similar Blood Pressure Reduction: A Meta‐Analysis in 20,451 Hypertensive Patients - Chi - 2016 - Angiotensin System Blockade Combined With Calcium Channel Blockers Is Superior to Other Combinations in Cardiovascular Protection With Similar Blood Pressure Reduction: A Meta‐Analysis in 20,451 Hypertensive Patients - Chi - 2016 -](https://onlinelibrary.wiley.com/cms/asset/04947eac-efed-46ca-9ede-af6ccff3f46f/jch12771-fig-0001-m.jpg)
Angiotensin System Blockade Combined With Calcium Channel Blockers Is Superior to Other Combinations in Cardiovascular Protection With Similar Blood Pressure Reduction: A Meta‐Analysis in 20,451 Hypertensive Patients - Chi - 2016 -
![PDF] Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence | Semantic Scholar PDF] Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8a85a1b016cfa016c3fcff4474ccd17a81263d78/2-Figure1-1.png)
PDF] Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence | Semantic Scholar
![Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up | Scientific Reports Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-81373-7/MediaObjects/41598_2021_81373_Fig1_HTML.png)
Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up | Scientific Reports
![Randomised controlled trial of a Calcium Channel or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Regime to Reduce Blood Pressure Variability following Ischaemic Stroke (CAARBS): a protocol for a feasibility study | BMJ Randomised controlled trial of a Calcium Channel or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Regime to Reduce Blood Pressure Variability following Ischaemic Stroke (CAARBS): a protocol for a feasibility study | BMJ](https://bmjopen.bmj.com/content/bmjopen/9/2/e025301/F1.large.jpg)
Randomised controlled trial of a Calcium Channel or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Regime to Reduce Blood Pressure Variability following Ischaemic Stroke (CAARBS): a protocol for a feasibility study | BMJ
![The Combination of Beta-Blockers and ACE Inhibitors Across the Spectrum of Cardiovascular Diseases | SpringerLink The Combination of Beta-Blockers and ACE Inhibitors Across the Spectrum of Cardiovascular Diseases | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10557-021-07248-1/MediaObjects/10557_2021_7248_Fig1_HTML.png)
The Combination of Beta-Blockers and ACE Inhibitors Across the Spectrum of Cardiovascular Diseases | SpringerLink
![Role of combination therapy with ACE inhibitors and calcium channel blockers in renal protection - ScienceDirect Role of combination therapy with ACE inhibitors and calcium channel blockers in renal protection - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0085253815488337-gr1.gif)
Role of combination therapy with ACE inhibitors and calcium channel blockers in renal protection - ScienceDirect
![Therapeutic impact of the single fixed-dose combination with a high-dose angiotensin-receptor blocker and a low-dose thiazide diuretic in the management of hypertension: awaiting further accumulation of clinical evidence | Hypertension Research Therapeutic impact of the single fixed-dose combination with a high-dose angiotensin-receptor blocker and a low-dose thiazide diuretic in the management of hypertension: awaiting further accumulation of clinical evidence | Hypertension Research](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fhr.2014.130/MediaObjects/41440_2014_Article_BFhr2014130_Fig1_HTML.jpg)
Therapeutic impact of the single fixed-dose combination with a high-dose angiotensin-receptor blocker and a low-dose thiazide diuretic in the management of hypertension: awaiting further accumulation of clinical evidence | Hypertension Research
![Amlodipine and valsartan: calcium channel blockers/angiotensin II receptor blockers combination for hypertension | Semantic Scholar Amlodipine and valsartan: calcium channel blockers/angiotensin II receptor blockers combination for hypertension | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8d3af8e44a76b39af4f881e01d2ab836f22a7c56/4-Figure2-1.png)
Amlodipine and valsartan: calcium channel blockers/angiotensin II receptor blockers combination for hypertension | Semantic Scholar
![PDF] Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic | Semantic Scholar PDF] Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/51a6538625b282517c313b1ea5fa0a11703b045c/3-Figure1-1.png)
PDF] Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic | Semantic Scholar
![Should ACE inhibitors or calcium channel blockers be used for post-transplant hypertension? | SpringerLink Should ACE inhibitors or calcium channel blockers be used for post-transplant hypertension? | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00467-020-04485-8/MediaObjects/467_2020_4485_Fig1_HTML.png)